EN IT

Evommune: technical bounce in the decline, MACD keeps falling

Evommune sell signal at week 12 — technical analysis shows a 7% bounce off the 20-day moving average, but MACD keeps declining and CMF stays negative, pointing to an ongoing decline, not a reversal.

Evommune: technical bounce in the decline, MACD keeps falling
Ongoing decline · week 12
Evommune: technical bounce in the decline, MACD keeps falling
June 19, 2026
Ongoing decline · week 12
In Summary
Evommune is at week 12 of a sell signal. This week the stock bounced 7% off the 20-day moving average, with buyers dominating volume. But MACD keeps falling and CMF remains negative: a technical bounce within the decline, not a reversal signal.
Ongoing decline ·12th week from start ·US stocks ·T2 ★ See Gold version →
IQS Phase
56
ordinary
Signal Strength
2
indecisive week
Sizing
MINIMUM
Ranking
#83 / 119
US stocks
Trade P&L %
+3.70%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn